Zafgen’s Mysterious Weight Loss Drug Advances Into First Trial for Obese Women – Xconomy

February 8th, 2010 by "Weight Loss" - Google News

Zafgen's Mysterious Weight Loss Drug Advances Into First Trial for Obese Women
Xconomy
The Cambridge, MA-based company was developing a powerful new weight loss drug made to work unlike any other treatment in development, by cutting off the ...

TagsTags:

Posted in Weight Loss News   Add a comment
Similar Weight Loss Posts

  • Orexigen Moves Forward with 2nd Obesity Drug: BioBuzz – TheStreet.com
    Orexigen Moves Forward with 2nd Obesity Drug: BioBuzzTheStreet.com(TheStreet) -- Orexigen Therapeutics(OREX Quote) released new weight-loss data Wednesday from the second of two obesity drugs in the company's development ...Orexigen to announce obesity drug data WednesdayReutersOrexigen(R) Therapeutics Phase 2b Trial for


  • Zafgen Plans Weight-Loss Study, Infinity CEO Perkins Plans for Growth, Boston … – Xconomy
    Zafgen Plans Weight-Loss Study, Infinity CEO Perkins Plans for Growth, Boston ...Xconomy... which the company hopes will be the first drug to produce weight loss dramatic enough to compete with stomach stapling and other bariatric surgery. ...


  • Weight Loss Drug Helps Treat Sleep Apnea – eFitnessNow
    dBTechnoWeight Loss Drug Helps Treat Sleep ApneaeFitnessNowA small, mid-stage trial of Qnexa an experimental weight-loss drug, was shown to lower sleep apnea, by 69% in a mid-stage trial. The study involved 45 obese ...Vivus drug cuts apnea in small trial;


  • Orexigen says Contrave obesity trials meet goals – Reuters
    ABC NewsOrexigen says Contrave obesity trials meet goalsReutersThe San Diego-based company said the results exceeded US Food and Drug Administration benchmarks for clinically significant weight loss and support its plan ...Investigational obesity treatment demonstrated improvements in ...Endocrine TodayOrexigen Obesity Drug


  • Weight Loss Drug Empatic Meets Study Goals – eMaxHealth
    Weight Loss Drug Empatic Meets Study GoalseMaxHealthThe weight loss drug Empatic, developed by Orexigen Therapeutics, Inc., met its main goals in its second Phase IIb clinical trial, which means researchers ...Orexigen says trial of 2nd obesity drug meets goalReutersThree Companies


    • Leave a Reply

    Security Code: